Ambrx Biopharma Inc. (AMAM) distance from 200-day Simple Moving Average is $2.45: Right on the Precipice

Ambrx Biopharma Inc. (NYSE: AMAM) started the day on March 16, 2023, with a price decrease of -4.07% at $10.13. During the day, the stock rose to $10.53 and sunk to $9.59 before settling in for the price of $10.56 at the close. Taking a more long-term approach, AMAM posted a 52-week range of $0.38-$13.07.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Nevertheless, stock’s Earnings Per Share (EPS) this year is -301.70%. This publicly-traded company’s shares outstanding now amounts to $38.62 million, simultaneously with a float of $5.52 million. The organization now has a market capitalization sitting at $358.10 million. At the time of writing, stock’s 50-day Moving Average stood at $4.15, while the 200-day Moving Average is $2.45.

It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 81 employees. It has generated 243,343 per worker during the last fiscal year. Meanwhile, its income per employee was -243,486. The stock had 49.45 Receivables turnover and 0.23 Total Asset turnover. For the Profitability, stocks gross margin was +94.55, operating margin was -101.91 and Pretax Margin of -99.75.

Ambrx Biopharma Inc. (AMAM) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. According to the most recent insider trade that took place on Mar 16, this organization’s 10% Owner bought 500,000 shares at the rate of 10.15, making the entire transaction reach 5,074,250 in total value, affecting insider ownership by 53,500,000. Preceding that transaction, on Mar 15, Company’s 10% Owner bought 250,000 for 10.60, making the whole transaction’s value amount to 2,648,875. This particular insider is now the holder of 53,000,000 in total.

Ambrx Biopharma Inc. (AMAM) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 6/29/2022, the organization reported -$1.33 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.09) by -$1.24. This company achieved a net margin of -100.06 while generating a return on equity of -42.72. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Ambrx Biopharma Inc.’s EPS decrease for this current 12-month fiscal period is -301.70% and is forecasted to reach -0.23 in the upcoming year.

Ambrx Biopharma Inc. (NYSE: AMAM) Trading Performance Indicators

Let’s observe the current performance indicators for Ambrx Biopharma Inc. (AMAM). It’s Quick Ratio in the last reported quarter now stands at 4.70. The Stock has managed to achieve an average true range (ATR) of 1.46. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 68.86.

In the same vein, AMAM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.26, and analysts are predicting that it will be -0.23 at the market close of one year from today.

Technical Analysis of Ambrx Biopharma Inc. (AMAM)

If we take a close look at the recent performances of Ambrx Biopharma Inc. (NYSE: AMAM), its last 5-days Average volume was 1.91 million that shows plunge from its year to date volume of 5.54 million. During the previous 9 days, stock’s Stochastic %D was recorded 61.87% While, its Average True Range was 1.63.

Raw Stochastic average of Ambrx Biopharma Inc. (AMAM) in the period of the previous 100 days is set at 76.83%, which indicates a major rise in contrast to 64.92% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 325.88% that was lower than 438.40% volatility it exhibited in the past 100-days period.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

Planet Fitness Inc. (PLNT) is heading in the right direction with an average volume of $913.99K

Planet Fitness Inc. (NYSE: PLNT) established initial surge of 1.44% at $76.71, as the Stock market unbolted on March 30, 2023. During the day,...

GrowGeneration Corp. (GRWG) recently have taken one step ahead with the beta value of 3.13

As on March 30, 2023, GrowGeneration Corp. (NASDAQ: GRWG) started slowly as it slid -2.99% to $3.24. During the day, the stock rose to...

A Little Luck Can Go a Long Way with Arcturus Therapeutics Holdings Inc. (ARCT) as it 5-day change was 36.69%

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) started the day on March 30, 2023, with a price increase of 2.33% at $20.64. During the day,...


Please enter your comment!
Please enter your name here